IGFBP7 Antikörper (C-Term)
Kurzübersicht für IGFBP7 Antikörper (C-Term) (ABIN633886)
Target
Alle IGFBP7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- IGFBP7 antibody was raised against the C terminal of IGFBP7
-
Aufreinigung
- Affinity purified
-
Immunogen
- IGFBP7 antibody was raised using the C terminal of IGFBP7 corresponding to a region with amino acids RGGPEKHEVTGWVLVSPLSKEDAGEYECHASNSQGQASASAKITVVDALH
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
IGFBP7 Blocking Peptide, (ABIN5614158), is also available for use as a blocking control in assays to test for specificity of this IGFBP7 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of IGFBP7 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- IGFBP7 (Insulin-Like Growth Factor Binding Protein 7 (IGFBP7))
-
Andere Bezeichnung
- IGFBP7
-
Hintergrund
- IGFBP7 contains 1 Ig-like C2-type (immunoglobulin-like) domain, 1 IGFBP N-terminal domain and 1 Kazal-like domain. It binds IGF-I and IGF-II with a relatively low affinity. IGFBP7 stimulates prostacyclin (PGI2) production.
-
Molekulargewicht
- 29 kDa (MW of target protein)
-
Pathways
- Growth Factor Binding
Target
-